Stocks and Investing Stocks and Investing
Thu, August 19, 2021
Wed, August 18, 2021

Matthew Harrison Maintained (AVIR) at Buy with Increased Target to $37 on, Aug 18th, 2021


Published on 2024-10-27 17:42:02 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Buy with Increased Target from $35 to $37 on, Aug 18th, 2021.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources